There is a close relationship between dyslipidemia and IL6 and insulin resistance where insulin resistance, or insufficient insulin secretion, can promote the secretion of large amounts of IL6 by pancreatic islet cells, thereby over activating B and T lymphocytes, as well as interacting with other cytokines. This evidence concerns the gene INS and metabolic syndrome.